CryoLife has hit back at claims that it has “repeatedly breached” terms of a distribution contract with haemostatic technology specialist Medafor, saying that its partner is, in fact, the one to blame. On 18 March, Medafor said it had effectively cancelled an exclusive deal ...
Please Login to read the full article.
